Results 171 to 180 of about 3,693,718 (332)

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

"¿Nuevos o viejos debates? Las representaciones sociales y el desarrollo moderno de las Ciencias Sociales"

open access: yesRevista de Estudios Sociales, 2006
The following article presents a debate on the different approaches social sciences have assumed on regards to social representations. With this in mind an analytical review is done, starting with the classical perspective (Durkheim, Mauss), all through ...
Carlos Andrés Charry Joya
doaj  

Recent advances in graphene-based biosensor technology with applications in life sciences. [PDF]

open access: yesJ Nanobiotechnology, 2018
Peña-Bahamonde J   +3 more
europepmc   +1 more source

Light-induced catalytic and cytotoxic properties of phosphorescent transition metal compounds with a d8 electronic configuration

open access: yesPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2013
Wai‐Pong To   +3 more
semanticscholar   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Bioinformatics Applications in Life Sciences and Technologies. [PDF]

open access: yesBiomed Res Int, 2016
Sousa SA   +5 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy